2017
DOI: 10.1200/jco.2017.35.15_suppl.e14033
|View full text |Cite
|
Sign up to set email alerts
|

The MetAction project: Biomarker-directed molecularly matched therapy for end-stage cancer implemented in clinical practice.

Abstract: e14033 Background: The MetAction project consists of two clinical trial phases. The completed first phase established the required diagnostic infrastructure, implemented security-approved systems for handling of sensitive information, educated the entire project staff within the context of tumor boards, and estimated costs of the initiative within public health services. The endeavor enabled expedite and safe mutation profiling of metastatic tumors in order to offer biomarker-based treatment with molecularly … Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles